| View |
|
VR-3474
|
Vitamin B-Complex
|
Hepaxivit
|
[see reverse]
|
Solution for Injection (IM/SC)
|
-
|
JSN Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 June 2021
|
29 July 2026
|
| View |
|
VR-3746
|
Marbofloxacin (Vet.)
|
Forcyl
|
160mg/ mL
|
Solution for Injection (IM/IV)
|
-
|
Vetoquinol
|
France
|
Automatic Renewal
|
01 October 2021
|
22 September 2026
|
| View |
|
DRP-7361-06
|
Spironolactone
|
Zydactin 50
|
50 mg
|
Tablet
|
Diuretic
|
Maxtar Bio-Genics
|
India
|
-
|
22 December 2021
|
04 October 2026
|
| View |
|
DRP-12382-04
|
Sodium Bicarbonate
|
Konabi
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.)
|
-
|
Jeil Pharmaceutical Co., Ltd.
|
Korea
|
-
|
13 February 2023
|
29 July 2027
|
| View |
|
DRP-12382-01
|
Sodium Bicarbonate
|
Alkacent
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.)
|
Electrolyte Solutions
|
Jeil Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
20 September 2022
|
29 July 2027
|
| View |
|
DRP-11661-05
|
Propofol
|
Delexofol
|
10 mg/mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Daewon Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
22 July 2023
|
07 April 2027
|
| View |
|
DRP-11661-03
|
Propofol
|
Profol-S
|
10 mg/mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Daewon Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
20 September 2022
|
07 August 2027
|
| View |
|
DRP-12995
|
Etoricoxib
|
Orixa
|
90 mg
|
Film-coated Tablet
|
-
|
PT Dexa Medica
|
Indonesia
|
Initial (re-application)
|
15 November 2022
|
15 November 2027
|
| View |
|
BRP-063-03
|
Enoxaparin sodium
|
Enoxar
|
2,000 IU Anti-Factor Xa (equivalent to 20 mg)/ 0.2 mL
|
Solution for Injection (IV/SC)
|
Antithrombotic agents
|
Brawn Laboratories Limited
|
India
|
Renewal
|
22 July 2023
|
15 August 2026
|
| View |
|
DRP-1182-06
|
Cetirizine Dihydrochloride
|
Metirizine
|
10 mg
|
Tablet
|
H1-Receptor Antagonist (Antihistamine)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
27 July 2023
|
16 December 2028
|
| View |
|
DRP-13346-01
|
Epinephrine
|
Esphrine
|
1 mg / mL
|
Solution for Injection (I.M/I.V/S.C)
|
Adrenergic and Dopaminergic Agent
|
Maxitech Pharma (Pvt) Ltd
|
Pakistan
|
Renewal
|
21 July 2023
|
01 February 2028
|
| View |
|
DRP-1557-07
|
Betahistine Dihydrochloride
|
Vexamine
|
16 mg
|
Tablet
|
Anti-Vertigo
|
Synmedic Laboratories
|
India
|
Renewal
|
21 July 2023
|
04 October 2027
|
| View |
|
DRP-3746-01
|
Co-Amoxiclav
|
Amoclav
|
500 mg/ 100 mg
|
Powder for Injection
|
Antibacterial (Combination of penicillin incl. beta-lactamase inhibitors)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
Renewal
|
19 July 2023
|
15 August 2027
|
| View |
|
DRP-4302-03
|
Betahistine Dihydrochloride
|
Vexamine
|
8 mg
|
Tablet
|
Anti-Vertigo
|
Synmedic Laboratories
|
India
|
Renewal
|
12 July 2023
|
29 September 2027
|
| View |
|
DRP-4786-03
|
Quetiapine (as fumarate)
|
Qvex
|
100 mg
|
Film-Coted Tablet
|
Antipsychotics
|
Sydler Remedies Pvt. Ltd
|
India
|
Renewal
|
21 July 2023
|
11 October 2028
|
| View |
|
DRP-4815-06
|
Lactulose
|
Lactucare
|
3.35g/5 mL
|
Syrup
|
Osmotic Laxative
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
Renewal
|
22 July 2023
|
10 February 2027
|
| View |
|
DRP-6167-04
|
Memantine Hydrochloride
|
Vexlin
|
10 mg
|
Film-Coated Tablet
|
Anti-dementia
|
Sydler Remedies Pvt. Ltd.
|
India
|
Renewal
|
29 June 2024
|
05 June 2030
|
| View |
|
DRP-9975-09
|
Cefuroxime (as axetil)
|
Roxxin-500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
Renewal
|
14 August 2023
|
01 July 2026
|
| View |
|
DRP-13438
|
Nystatin
|
Fungyst
|
100,000 IU/mL
|
Oral Suspension
|
Antifungal
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
04 July 2023
|
16 November 2028
|
| View |
|
DRP-4781-01
|
L-Asparaginase
|
None
|
5000 IU
|
Lyophilized Powder for Injection
|
Antineoplastic Agent
|
Celon Laboratories Private Limited
|
India
|
Renewal
|
08 July 2023
|
11 October 2028
|